| Financial Year |
March 31 2023 |
| Monetary Funds |
820,024,973.68 |
| Held-for-trading Financial Assets |
120,405,593.15 |
| Notes Receivable |
433,033,856.96 |
| Accounts Receivable |
704,823,782.31 |
| Advances to Suppliers |
33,830,699.91 |
| Other Receivables |
5,941,804.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
694,044,630.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,758,337.31 |
| Total Current Assets |
3,124,493,138.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
421,014,934.12 |
| Investment Properties |
36,125,676.64 |
| Fixed Assetes |
1,186,267,023.93 |
| Under-construction Projects |
256,143.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
280,169,100.59 |
| R&D expenses |
106,132.07 |
| Goodwill |
135,273,331.90 |
| Long-Term Deferred and Prepaid Expenses |
7,587,103.06 |
| Deferred Income Tax Assets |
93,124,138.90 |
| Other Non-Current Assets |
36,720,997.30 |
| Sub-Total of Non-Current Assets |
2,417,502,931.73 |
| Total Assets |
5,541,996,070.38 |
| Short-Term Loans |
6,069,973.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
158,358,101.91 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,627,596.69 |
| Taxes Payable |
72,265,131.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
880,400,766.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,368,108.76 |
| Other Current Liabilities |
42,725,672.02 |
| Sub-Total of Current Liabilities |
1,302,241,702.55 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,189,062.45 |
| Deferred Income Tax Liabilities |
42,976,140.59 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
96,307,374.02 |
| Total Liabilities |
1,398,549,076.57 |
| Paid-In Capital(Or Share Stock) |
855,942,012.00 |
| Capital Surplus |
1,548,926,585.48 |
| Surplus Reserve |
448,150,521.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,307,812,561.59 |
| Minority Stockholder's Interest |
-3,823,761.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,147,270,755.21 |
| Owner's Equity（Stockholder's Equity） |
4,143,446,993.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,541,996,070.38 |
